Sanofi SA (SAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.152x

Based on the latest financial reports, Sanofi SA (SAN) has a cash flow conversion efficiency ratio of 0.152x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€10.92 Billion ≈ $12.76 Billion USD) by net assets (€71.71 Billion ≈ $83.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Sanofi SA's balance sheet to measure how much of total assets are equity-financed.

Sanofi SA - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Sanofi SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sanofi SA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Sanofi SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sanofi SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Prosus N.V.
AS:PRX
0.024x
Brookfield Corporation
TO:BN
0.018x
Marriott International Inc
NASDAQ:MAR
-0.210x
Newmont Corporation
AU:NEM
0.108x
Quanta Services Inc
NYSE:PWR
0.043x
Mizuho Financial Group Inc
F:MZ8A
N/A
McKesson Corporation
NYSE:MCK
-4.102x
Enel SpA
F:ENLA
0.103x

Annual Cash Flow Conversion Efficiency for Sanofi SA (1999–2025)

The table below shows the annual cash flow conversion efficiency of Sanofi SA from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Sanofi SA (SAN) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €71.71 Billion
≈ $83.84 Billion
€10.92 Billion
≈ $12.76 Billion
0.152x +30.52%
2024-12-31 €77.86 Billion
≈ $91.02 Billion
€9.08 Billion
≈ $10.62 Billion
0.117x -15.46%
2023-12-31 €74.35 Billion
≈ $86.93 Billion
€10.26 Billion
≈ $11.99 Billion
0.138x -4.30%
2022-12-31 €73.02 Billion
≈ $85.36 Billion
€10.53 Billion
≈ $12.31 Billion
0.144x -5.42%
2021-12-31 €69.03 Billion
≈ $80.70 Billion
€10.52 Billion
≈ $12.30 Billion
0.152x +29.67%
2020-12-31 €63.37 Billion
≈ $74.08 Billion
€7.45 Billion
≈ $8.71 Billion
0.118x -10.28%
2019-12-31 €59.11 Billion
≈ $69.10 Billion
€7.74 Billion
≈ $9.05 Billion
0.131x +39.43%
2018-12-31 €59.03 Billion
≈ $69.02 Billion
€5.55 Billion
≈ $6.49 Billion
0.094x -25.84%
2017-12-31 €58.24 Billion
≈ $68.09 Billion
€7.38 Billion
≈ $8.63 Billion
0.127x -6.69%
2016-12-31 €57.72 Billion
≈ $67.49 Billion
€7.84 Billion
≈ $9.16 Billion
0.136x -11.39%
2015-12-31 €58.21 Billion
≈ $68.05 Billion
€8.92 Billion
≈ $10.43 Billion
0.153x +12.12%
2014-12-31 €56.27 Billion
≈ $65.78 Billion
€7.69 Billion
≈ $8.99 Billion
0.137x +12.09%
2013-12-31 €57.03 Billion
≈ $66.68 Billion
€6.95 Billion
≈ $8.13 Billion
0.122x -14.25%
2012-12-31 €57.47 Billion
≈ $67.18 Billion
€8.17 Billion
≈ $9.55 Billion
0.142x -13.99%
2011-12-31 €56.37 Billion
≈ $65.91 Billion
€9.32 Billion
≈ $10.89 Billion
0.165x -9.73%
2010-12-31 €53.29 Billion
≈ $62.30 Billion
€9.76 Billion
≈ $11.41 Billion
0.183x +4.20%
2009-12-31 €48.45 Billion
≈ $56.64 Billion
€8.52 Billion
≈ $9.95 Billion
0.176x -7.05%
2008-12-31 €45.07 Billion
≈ $52.69 Billion
€8.52 Billion
≈ $9.96 Billion
0.189x +18.82%
2007-12-31 €44.72 Billion
≈ $52.28 Billion
€7.12 Billion
≈ $8.32 Billion
0.159x +10.43%
2006-12-31 €45.82 Billion
≈ $53.57 Billion
€6.60 Billion
≈ $7.72 Billion
0.144x +4.42%
2005-12-31 €46.32 Billion
≈ $54.15 Billion
€6.39 Billion
≈ $7.47 Billion
0.138x +42.35%
2004-12-31 €41.52 Billion
≈ $48.54 Billion
€4.03 Billion
≈ $4.71 Billion
0.097x -72.86%
2003-12-31 €6.33 Billion
≈ $7.40 Billion
€2.26 Billion
≈ $2.64 Billion
0.357x +29.04%
2002-12-31 €6.06 Billion
≈ $7.08 Billion
€1.68 Billion
≈ $1.96 Billion
0.277x -11.84%
2001-12-31 €5.79 Billion
≈ $6.77 Billion
€1.82 Billion
≈ $2.13 Billion
0.314x +13.46%
2000-12-31 €4.33 Billion
≈ $5.06 Billion
€1.20 Billion
≈ $1.40 Billion
0.277x +20.71%
1999-12-31 €3.61 Billion
≈ $4.22 Billion
€828.00 Million
≈ $968.02 Million
0.229x --

About Sanofi SA

PA:SAN France Drug Manufacturers - General
Market Cap
$108.59 Billion
€92.88 Billion EUR
Market Cap Rank
#262 Global
#10 in France
Share Price
€76.91
Change (1 day)
-0.56%
52-Week Range
€72.49 - €90.44
All Time High
€109.62
About

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting aga… Read more